Systematic Screening for COPD in Tabacology Consultation
Completed
- Conditions
- Smoking Cessation
- Registration Number
- NCT04843605
- Lead Sponsor
- University Hospital, Brest
- Brief Summary
COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities.
Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry.
The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway.
The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 112
Inclusion Criteria
- Subjects over 45 years old, followed in Tabacology unit at CHRU of BREST - No COPD patient or COPD patients not followed for more than 3 years (considered out of care)
- No opposition filed
Exclusion Criteria
- Patients already followed for COPD
- Contraindication to spirometry
- Refusal to participate
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method COPD DIAGNOSIS day 1 The diagnosis of COPD is performed using a spirometry
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Brest
🇫🇷Brest, France